Atropine is often used as a first line treatment of a third-degree heart block in the presence of a narrow QRS which indicates a nodal block, but, may have little to no effect in an infra-nodal block. Atropine works by reducing
vagal stimulation through the AV node but will not be effective in those who have had a previous heart transplant. Other drugs may be utilized such as
epinephrine or
dopamine which have positive
chronotropic effects and may increase the heart rate. Treatment in emergency situations can involve electrical
transcutaneous pacing in those who are acutely hemodynamically unstable and can be used regardless of the persons level of consciousness. Sedative agents such as a
benzodiazepine or
opiate may be used in conjunction with transcutaneous pacing to reduce the pain caused by the intervention. Third-degree AV block can be treated more permanently with the use of a dual-chamber
artificial pacemaker. This type of device typically listens for a pulse from the SA node via lead in the right atrium and sends a pulse via a lead to the right ventricle at an appropriate delay, driving both the right and left ventricles. Pacemakers in this role are usually programmed to enforce a minimum heart rate and to record instances of
atrial flutter and
atrial fibrillation, two common secondary conditions that can accompany third-degree AV block. Since pacemaker correction of the third-degree block requires full-time pacing of the ventricles, a potential side effect is
pacemaker syndrome, and may necessitate the use of a
biventricular pacemaker, which has an additional 3rd lead placed in a vein in the left ventricle, providing more coordinated pacing of both ventricles. The 2005 Joint European Resuscitation and Resuscitation Council (UK) guidelines state that atropine is the first-line treatment especially if there were any adverse signs, namely: 1) heart rate 3 seconds.
Mobitz Type 2 AV block is another indication for pacing. As with other forms of heart block,
secondary prevention may also include medicines to control blood pressure and atrial fibrillation, as well as lifestyle and dietary changes to reduce risk factors associated with
heart attack and
stroke. Early treatment of atrioventricular blockade is based on the presence and severity of symptoms and signs associated with ventricular escape rhythm. Hemodynamically unstable patients require immediate medication and in most cases temporary pacing to increase heart rate and cardiac output. Once the patient is hemodynamically stable, a potentially reversible cause should be evaluated and treated. If no reversible cause is identified, a permanent pacemaker is inserted. Most stable patients have persistent bradycardia-related symptoms and require identification and treatment of any reversible cause or permanent implantable pacemaker. Reversible causes of complete AV block should be ruled out before the insertion of a permanent pacemaker, such as drugs that slow heart rate and which induce hyperkalemia. Complete atrioventricular block in acute myocardial infarction should be treated with temporary pacing and revascularization. Complete atrioventricular block caused by hyperkalemia should be treated to lower serum potassium levels and patients with hypothyroidism should also receive thyroid hormone. If there is no reversible cause, the clear treatment of complete atrioventricular block is mostly permanent pacemaker placement. ==Prognosis==